These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 22099723)

  • 21. C57BL/6 mice genetically deficient in IL-12/IL-23 and IFN-gamma are susceptible to experimental autoimmune myasthenia gravis, suggesting a pathogenic role of non-Th1 cells.
    Wang W; Milani M; Ostlie N; Okita D; Agarwal RK; Caspi RR; Conti-Fine BM
    J Immunol; 2007 Jun; 178(11):7072-80. PubMed ID: 17513756
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocyte-macrophage colony-stimulating factor prevents diabetes development in NOD mice by inducing tolerogenic dendritic cells that sustain the suppressive function of CD4+CD25+ regulatory T cells.
    Gaudreau S; Guindi C; Ménard M; Besin G; Dupuis G; Amrani A
    J Immunol; 2007 Sep; 179(6):3638-47. PubMed ID: 17785799
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Suppression of experimental autoimmune myasthenia gravis by autologous T regulatory cells.
    Aricha R; Reuveni D; Fuchs S; Souroujon MC
    J Autoimmun; 2016 Feb; 67():57-64. PubMed ID: 26489998
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunization with Recombinantly Expressed LRP4 Induces Experimental Autoimmune Myasthenia Gravis in C57BL/6 Mice.
    Ulusoy C; Çavuş F; Yılmaz V; Tüzün E
    Immunol Invest; 2017 Jul; 46(5):490-499. PubMed ID: 28375749
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cathepsin S is required for murine autoimmune myasthenia gravis pathogenesis.
    Yang H; Kala M; Scott BG; Goluszko E; Chapman HA; Christadoss P
    J Immunol; 2005 Feb; 174(3):1729-37. PubMed ID: 15661938
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Tolerogenic bone marrow-derived dendritic cells induce neuroprotective regulatory T cells in a model of Parkinson's disease.
    Schutt CR; Gendelman HE; Mosley RL
    Mol Neurodegener; 2018 May; 13(1):26. PubMed ID: 29783988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. In vitro and in vivo actions of acetylcholine receptor educated suppressor T cell lines in murine experimental autoimmune myasthenia gravis.
    Pachner AR; Kantor FS
    Clin Exp Immunol; 1984 Jun; 56(3):659-68. PubMed ID: 6235071
    [TBL] [Abstract][Full Text] [Related]  

  • 28. GM-CSF-induced, bone-marrow-derived dendritic cells can expand natural Tregs and induce adaptive Tregs by different mechanisms.
    Bhattacharya P; Gopisetty A; Ganesh BB; Sheng JR; Prabhakar BS
    J Leukoc Biol; 2011 Feb; 89(2):235-49. PubMed ID: 21048215
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis.
    Chae CS; Kwon HK; Hwang JS; Kim JE; Im SH
    PLoS One; 2012; 7(12):e52119. PubMed ID: 23284891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. T cells of mice treated with mPEG-myasthenogenic peptide conjugate are involved in protection against EAMG by stimulating lower pathogenic antibody responses.
    Oshima M; Atassi MZ
    Autoimmunity; 2000; 32(1):45-55. PubMed ID: 10958175
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Acetylcholine receptor-induced experimental myasthenia gravis: what have we learned from animal models after three decades?
    Baggi F; Antozzi C; Toscani C; Cordiglieri C
    Arch Immunol Ther Exp (Warsz); 2012 Feb; 60(1):19-30. PubMed ID: 22159475
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4 costimulation is not required in a novel LPS-enhanced model of myasthenia gravis.
    Allman W; Qi H; Saini SS; Li J; Tuzun E; Christadoss P
    J Neuroimmunol; 2012 Aug; 249(1-2):1-7. PubMed ID: 22626443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. ATRA alters humoral responses associated with amelioration of EAMG symptoms by balancing Tfh/Tfr helper cell profiles.
    Xie X; Mu L; Yao X; Li N; Sun B; Li Y; Zhan X; Wang X; Kang X; Wang J; Liu Y; Zhang Y; Wang G; Wang D; Liu X; Kong Q; Li H
    Clin Immunol; 2013 Aug; 148(2):162-76. PubMed ID: 23773919
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Experimental autoimmune myasthenia gravis in naive non-obese diabetic (NOD/LtJ) mice: susceptibility associated with natural IgG antibodies to the acetylcholine receptor.
    Quintana FJ; Pitashny M; Cohen IR
    Int Immunol; 2003 Jan; 15(1):11-6. PubMed ID: 12502721
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Suppression of ongoing experimental autoimmune myasthenia gravis by transfer of RelB-silenced bone marrow dentritic cells is associated with a change from a T helper Th17/Th1 to a Th2 and FoxP3+ regulatory T-cell profile.
    Yang H; Zhang Y; Wu M; Li J; Zhou W; Li G; Li X; Xiao B; Christadoss P
    Inflamm Res; 2010 Mar; 59(3):197-205. PubMed ID: 19768385
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Induction of suppressor cells specific for AChR in experimental autoimmune myasthenia gravis.
    McIntosh KR; Drachman DB
    Science; 1986 Apr; 232(4748):401-3. PubMed ID: 2938256
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Experimental Autoimmune Myasthenia Gravis (EAMG): from immunochemical characterization to therapeutic approaches.
    Fuchs S; Aricha R; Reuveni D; Souroujon MC
    J Autoimmun; 2014 Nov; 54():51-9. PubMed ID: 24970384
    [TBL] [Abstract][Full Text] [Related]  

  • 38. GM-CSF therapy inhibits chronic graft-versus-host disease via expansion of regulatory T cells.
    Hotta M; Yoshimura H; Satake A; Tsubokura Y; Ito T; Nomura S
    Eur J Immunol; 2019 Jan; 49(1):179-191. PubMed ID: 30457669
    [TBL] [Abstract][Full Text] [Related]  

  • 39. OX40L/Jagged1 cosignaling by GM-CSF-induced bone marrow-derived dendritic cells is required for the expansion of functional regulatory T cells.
    Gopisetty A; Bhattacharya P; Haddad C; Bruno JC; Vasu C; Miele L; Prabhakar BS
    J Immunol; 2013 Jun; 190(11):5516-25. PubMed ID: 23630352
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cellular immune response to acetylcholine receptors in murine experimental autoimmune myasthenia gravis: inhibition with monoclonal anti-I-A antibodies.
    Christadoss P; Lindstrom J; Talal N
    Cell Immunol; 1983 Oct; 81(1):1-8. PubMed ID: 6577968
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.